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Abstract
Colonizing commensal bacteria after birth are required for the proper development of the gastrointestinal tract. It is
believed that bacterial colonization pattern in neonatal gut affects gut barrier function and immune system maturation.
Studies on the development of faecal microbiota in infants showed that the neonatal gut was first colonized with
enterococci followed by other microbiota such as Bifidobacterium. Other studies showed that babies who developed allergy
were less often colonized with Enterococcus during the first month of life as compared to healthy infants. Many studies have
been conducted to elucidate how bifidobacteria or lactobacilli, some of which are considered probiotic, regulate infant gut
immunity. However, fewer studies have been focused on enterococi. In our study, we demonstrate that E. faecalis, isolated
from healthy newborns, suppress inflammatory responses activated in vivo and in vitro. We found E. faecalis attenuates
proinflammatory cytokine secretions, especially IL-8, through JNK and p38 signaling pathways. This finding shed light on
how the first colonizer, E.faecalis, regulates inflammatory responses in the host.
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Introduction
Significant controversy exists over the role of Enterococcus, and
more specifically E.faecalis, on health. Whereas, in clinical settings
with immune-compromised patients, E.faecalis can be considered
an opportunistic pathogen [1], it has also been shown to impart
beneficial effects to health. A recent in vitro study demonstrated
that E. faecalis was inhibitory to C. jejuni MB 4185 infection under
simulated broiler caecal condition [2]. An E.faecalis isolated from a
healthy adult showed the highest probiotic activity when
compared with over 70 other lactic acid bacteria (LAB) isolates,
including lactobacilli and bifidobacteria [3]. These contrasting
roles suggest an interplay between bacteria and human host that is
context-dependent and likely dynamic over time.
Prior to birth, the gut is sterile and bacteria start to colonize
after birth. The neonatal gut, with a naı¨ve but competent immune
system, represents a valuable context for determining the role of
particular bacteria in health. Proper development of the gastro-
intestinal tract requires timely colonization after birth [4]. Study
showed microbiota acquisition in infancy is likely a determinant of
early immune programming, subsequent infection, and allergy risk
[5]. Among the first wave of microorganisms detected in the stool
of infants, enterococci are commonly found on the first day of life
[6,7]. They gradually decrease with concurrent increases in
bifidobacteria that appear within 2–3 days in breast fed infants [8].
Babies who developed allergies were less often colonized with
Enterococcus during the first month of life as compared to healthy
infants [9]. This implies that Enterococcus could have major impact
on intestinal immune development in the very early stage of life.
Several factors, such as mode of delivery and gestational age,
are known to influence the composition of microbial flora in early
stage of life. Preterm infants and infants delivered via cesarean
section display a delayed intestinal colonization with smaller
species variability and a higher occurrence of potentially
pathogenic microorganism [10,11]. Pre-term births are far more
likely to suffer necrotizing enterocolitis (NEC) than are births at
term [12]. Interestingly, infants who developed NEC carry less
E.faecalis [13]. Previous studies have shown that serum concentra-
tions of IL-8 were elevated in severe cases of NEC from its onset
through the first 24 hours [14]. IL-8 is a chemokine that stimulates
migration of neutrophils from intravascular to interstitial sites and
can directly activate neutrophils and regulate the expression of
neutrophil adhesion molecules [15–17]. Thus, IL-8 plays an
important role in infant infections.
It is also known that cell-wall components from Gram-negative
such as lipopolysaccarides as well as host-derived cytokines such as
IL-1b and TNF-a, increase IL-8 secretion from IECs through the
activation of mitogen activated protein kinase (MAPK) [18,19]. At
least three groups of MAPKs have been identified. These include
the extracellular signal-regulated kinases (ERKs), the c-JUN NH2-
terminal kinases (JNKs) and p38. P38 was reported to stabilize IL-
8 mRNA and its level was increased in the muscularis propria of
colonic tissue both in DSS colitis mice and patients with
inflammatory bowel disease (IBD) [20]. A p38 inhibitor suppressed
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inflammation in DSS-induced colitis model by reducing mucosal
IL-1b and TNF-a levels [21]. Inhibition of JNK activation
correlated with suppression of IL-1b-induced IL-8 secretion in
IECs [22]. Study showed activation of the ERK signaling pathway
in response to TNF-a in HT-29 cells leads to increased expression
of IL-8 [23].
Extensive studies have been performed to determine how
lactobacilli and bifidobacteria regulate infant gut immunity
[24,25]. However, few studies have focused on E.faecalis, which
is the first colonizer in the human GI tract [6,7]. Here, we
demonstrate that E. faecalis, isolated from newborns, can suppress
pathogen-mediated inflammatory responses in human IECs as
well as DSS-induced inflammation in mice model. E. faecalis
attenuates proinflammatory cytokine secretions, especially IL-8,
via distinct pathways. These bacteria suppress JNK and p38 as
well as disrupt c-JUN-regulated inflammatory responses. These
findings shed lights on functions of the first colonizer, E.faecalis, in
infant gut protection.
Results
Isolation and identification of bacteria from infants’ gut
In order to characterize early postnatal gut LABs, we collected
feces from 16 healthy infants aged 3 days and 1 month from
Indonesia. A total of 25 isolates were expanded and confirmed as
LABs based on lactic acid production, a rod or coccal shape, and
Gram positivity. Based on their carbohydrate fermentation
patterns, nine strains were categorized as Lactobacillus and 16
strains as Enterococcus. 16S rDNA sequence analysis showed that 8/
9 of the lactobacilli were Lactobacillus casei and 13/16 of the
enterococci were Enterococcus faecalis (Table 1). Thus, we found a
restricted diversity of early colonizing species in infants with L.casei
and E. faecalis being the prominent early colonizers. A phyloge-
netic tree, plotted based on a sequence distance method, is
provided (Figure 1). From the phylogenetic tree, we could see
some enterococcus were closer to lactobacillus than the rest
enterococcus.
Figure 1. Phylogeny tree of 25 bacterial strains isolated from new born infants according to their 16sRNA sequences.
doi:10.1371/journal.pone.0097523.g001
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Enterococcus faecalis suppress intestinal IL-8 secretion
We then examined how these early colonizing bacteria can
impact intestinal immunity and epithelial cell signaling. Potential
anti-inflammatory effects of infant-isolated enterococci and
lactobacilli were investigated by co-culturing them with colorectal
cancer-derived IECs (Caco-2, HT29 and HCT116). Supernatants
were harvested for IL-8 analysis as a marker for gut inflammation
[26]. Although some lactobacilli suppressed IL-8 secretion in
Caco-2 cells, none of the Lactobacillus isolates significantly
attenuated IL-8 secretion in all the three cell lines (Figure S1A–
C). In contrast, the majority of Enterococcus isolates suppressed IL-8
production in Caco-2 and HCT116 cells (Figure 2A, B). Strikingly,
four strains, namely EC1, EC3, EC15 and EC16, suppressed IL-8
secretion in all three lines (Figure 2 A–C and the reduction of IL-8
levels was not due to apoptosis induced by E.faecalis (Figure S1D,
E). We then tested the kinetics of IL-8 suppression by these four
strains in HCT116 cells (Figure 2D). For each of these isolates, the
degree of suppression of IL-8 was dependent on bacterial
multiplicity of infection (MOI). E. faecalis isolates suppressed IL-8
secretion from 4h at a MOI of 100. However, the same level of
suppression was observed much earlier at a MOI of 1000. In
contrast, this rapid and robust suppression of IL-8 was not seen
with commercial probiotic strains, L. rhamnosus GG (L.gg)
(Figure 2D). Salmonella typhimurium (Salm), a known pathogen and
stimulator of IL-8 [27], activated IL-8 secretion after 2 h
(Figure 2D). These data suggest that early colonizing E.faecalis
have potent anti-inflammatory effects as assessed using IL-8
expression as a marker.
Active E. faecalis physiology is not critical for suppression
of intestinal inflammation
We then investigated what aspects of E. faecalis may cause
reduced IL-8 secretion in IECs. In order to test if intact bacterial
physiology was critical for IL-8 suppression, we exposed HCT116
cells to live bacteria or bacteria that had been killed by ultraviolet
exposure (UV) or by physical disruption through sonication
immediately before use (Figure 3). In each case we found that IL-8
suppression remained intact, indicating that active bacterial
physiology was not critical for this activity. We then tested
whether physical contact between bacterial membranes and
epithelial cells was important. Physically separating live bacteria
from the epithelial cells, using a semi-permeable cell culture insert,
greatly relieved the IL-8 suppression (Figure 3), indicating that
physical contact between the bacteria and epithelial cells was
important for this activity. Furthermore, bacteria-conditioned
media from bacteria alone or from mammalian cell cocultures
resulted in no apparent IL-8 suppression (Figure 3), suggesting that
epithelial cells are responding to poorly soluble factor(s), likely
present on the exterior cell wall of E. faecalis.
Table 1. Identification of 25 isolates from infants.
Bacterial names Bacterial source (Infants Age) Strain ID obtained from 16S rDNA sequencing
L1 3day Staphylococcus hominis
L2 3day Lactobacillus casei
L5 3day Lactobacillus casei
L6 3day Lactobacillus casei
EC3 3day Enterococcus faecalis
EC6 3day Enterococcus faecalis
EC9 3day Enterococcus avium
EC14 3day Enterococcus faecium
EC15 3day Enterococcus faecalis
EC16 3day Enterococcus faecalis
L3 1month Lactobacillus casei
L4 1 month Lactobacillus casei
L7 1month Lactobacillus casei
L8 1month Lactobacillus casei
L9 1month Lactobacillus casei
EC1 1month Enterococcus faecalis
EC2 1month Enterococcus faecalis
EC4 1month Enterococcus faecalis
EC5 1month Enterococcus faecalis
EC7 1month Enterococcus faecalis
EC8 1month Enterococcus faecalis
EC10 1month Enterococcus faecalis
EC11 1 month Enterococcus gallinarum
EC12 1 month Enterococcus faecalis
EC13 1 month Enterococcus faecalis
doi:10.1371/journal.pone.0097523.t001
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E. faecalis suppresses IL-8 production induced by IL-1b,
TNF-a and S. typhimurium
We next tested the ability of E. faecalis to regulate IL-8
production induced by IL-1b (2 ng/ml), TNF-a (200 ng/ml) and
S. typhimurium (107 CFU/ml) in Caco-2 and HCT116 cells. We
found that E. faecalis EC16 suppressed IL-8 production induced by
IL-1b, TNF-a and S. typhimurium after 1 h of incubation. The
suppression of IL-8 production inside the cells was observed at
30 mins of treatment (Figure S2A,B). This phenomenon was
observed in both HCT116 (Figure 4A,B) and Caco-2 (Figure S2C)
cells. Interestingly, E. faecalis EC2 could not suppress IL-8
production either inside or outside of IECs, suggesting distinctive
ability of these four E. faecalis strains (EC1, EC3, EC15, EC16) in
regulating IL-8 production.
E. faecalis suppresses TNF-a expression induced by IL-1b
In addition to IL-8, we tested potential TNF-a regulation by E.
faecalis in HCT116 and Caco-2 cells. TNF-a is an important
regulator of epithelial inflammation. TNF-a levels are elevated in
both human inflammatory bowel diseases and animal models of
Figure 2. IL-8 secretion in IECs. IL-8 secretions in Caco-2 (A), HCT116 (B) and HT-29 (C) with the treatment of Enterococcus. A total number of
107 cfu/ml bacteria were added into the cells for 6 h. Supernatants were harvested for cytokine assay as described in Materials and Methods. (D)
HCT116 cells were co-cultured with E. faecalis (EC1, EC3, EC15, EC16) and L. rhamnosus GG (L.GG) and S. typhimurium (Salm) with a multiplicity of
infection (MOI) of 100 for 2 h, 4 h, 6 h and 24 hours. Three independent experiments were compiled to produce the data shown. Data were
expressed as mean value 6SD. Student’s T-test was used for statistical analysis as described in Materials and Methods. * p,0.05.
doi:10.1371/journal.pone.0097523.g002
Figure 3. IL-8 secretions in HCT116 cells. IL-8 production in HCT116 with the treatment of different conditional medium (CM) (from coculture
supernatant, from bacteria and from cell supernatant), cell inserts, UV killed and sonicated bacteria. Whole live bacteria were used as control as
described in Materials and Methods. Three independent experiments were done and data were expressed as mean value 6SD. Student’s T-test was
used for statistical analysis as described in Materials and Methods. * p,0.05.
doi:10.1371/journal.pone.0097523.g003
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intestinal inflammation [28–30]. As expected, we found that TNF-
a secretion from HCT116 (Figure 4C) and Caco-2 (Figure S2D)
cells were activated by IL-1b. This increase secretion, however,
was attenuated by E. faecalis EC16. Interestingly, ICAM1, IL-2,
IL-5, IL-17 and INF-c induction by IL-1b and S. typhimurium was
suppressed by EC16 in Caco-2 cells (Figure S2D).
E. faecalis regulates multiple immune-signaling pathways
Our finding that E.faecalis could suppress IL-8 expression led us
to investigate if these bacteria could regulate other immune-
signaling pathways. We tested immune-gene expression by the
four strains of E. faecalis (EC1, EC3, EC15, EC16) using cDNA
microarray analysis. Potential expression changes for 406
immune-signaling genes were assayed in Caco-2 cells after 6 hour
coculture with E. faecalis isolates. Acquired data from array
membranes were initially scanned (Figure S3A) and volcano plots
were obtained to identify statistically significant gene expression
changes (Figure S3B). A partial list of the genes that demonstrate
statistically significant expression changes (.1.5 fold) by cDNA
microarray analysis is provided in Table 2. From the data of
microarray, we found several signaling pathways that may be
involved in the anti-inflammatory effects of the four E. faecalis
strains. Using Ingenuity Pathway Analysis, we mainly identified
cytokine signaling (IL-1, IL-2, IL-6, IL-8 and IL-10 signaling),
SAPK/JNK signaling, P38 MAPK signaling and NF-kB signaling
are responsible for the responses (Figure 5A). Together these data
suggest that E. faecalis may alter multiple immunomodulatory
pathways simultaneously.
From the microarray analysis, we selected 46 genes for further
study using TLDA. The gene ID and Taqman probes are listed in
Table S1. Each of the four E. faecalis isolates demonstrated a
similar pattern on the immune-gene regulation in Caco-2 and
HCT116 cells. Data for gene-regulation by isolate EC16 is
provided as a representative example (Figure 5B). To our surprise,
we found that IL-8 mRNA was unregulated. We also found that
DUSP1, a reported MAPK phosphatase that can attenuate
MAPK signaling, was strongly upregulated. Other genes involved
in MAPK signaling were downregulated in Caco-2 cells, namely
MAP3K7IP1, a positive regulator of the MAP kinase cascade [31];
MKNK1, a target of ERK and activator of CREB-mediated
proliferation and differentiation [32] and MAPKAPK2, a target of
p38 MAP kinase involved in many cellular processes including
inflammatory responses (Figure S4A). Other MAPK family
members like MAPK7 in Caco-2 cells, MAPK9 in HCT116 cells
were also suppressed by E. faecalis (Figure S4B,C). From the above
data, we hypothesize that early-colonizing E. faecalis might
influence the inflammatory responses in the host by regulating
MAPK signaling pathway. Furthermore, consistent with observa-
tions from microarray, TLDA results also showed that NF-kB1
and IKBKB were suppressed by E. faecalis in both Caco-2 and
HCT116 cells (Figure S4D,E) suggesting that E. faecalis suppressed
NF-kB1 signaling pathway at transcriptional level.
E. faecalis suppresses activation of P38, P-JNK and C-JUN
Because factors regulating MAPK signaling were altered upon
E.faecalis exposure, we hypothesized that these bacteria may
attenuate IL-8 production, at least in part through inhibiting
MAPK pathways. To test this, we examine MAPK expression and
phosphorylation by immunoblotting. Whereas p-JNK was strongly
and transiently activated by IL-1b and S. typhimurium in HCT116
cells within half hour of treatment, E. faecalis suppressed this
activation (Figure 6A). Consistent with this finding, cJUN which is
downstream of JNK, was activated by IL-1b and S. typhimurium at
one hour while suppressed by E. faecalis EC16 (Figure 6B).
Similarly, the presence of phosphorylated p38 was increased by
incubation with either IL-1b or S. typhimurium at one hour, which
was abrogated by coculture with E. faecalis EC16 (Figure 6C).
Therefore, E. faecalis can inhibit JNK and p38 signaling as one
potential means of suppressing IL-8 production. In contrast, ERK
phosphorylation did not change upon the treatment of IL-1b, S.
typhimurium and E. faecalis (Figure S5), suggesting that ERK does
not impact IL-8 production in these cells. These data suggest that
E.faecalis may suppress inflammatory signaling in IECs through
reducing the activation of JNK and p38.
E.faecalis suppress IL-1b and TNF-a expression in DSS
induced colitis mice model
To examine the immunomodulatory effects of E.faecalis in vivo,
we induced colitis using Dextran Sulphate Sodium salt (DSS) in
mice and then treated them with E.faecalis EC16 or Lactobacillus
rhamnosus GG (L.gg), a well studied probiotic strain. Colon length,
which is an indicator of inflammation, was shortened by DSS
treatment. Consistent with an immunorepressive role, both
E.faecalis and L.gg significantly alleviated this shortening
(Figure 7A). Furthermore, E.faecalis as well as L.gg prevented
DSS-induced weight loss in these animals (Figure 7B). IL-1b and
TNF-a which were activated by DSS were significantly down
regulated by EC16 and L.gg (Figure 7C,D)
Discussion
In this study, we describe the isolation and primary character-
ization of E.faecalis strains isolated from healthy newborns in
Indonesia. E.faecalis represented the most frequently isolated
bacteria from the children and selected isolates possessed ability
to strongly inhibit inflammatory markers in IECs. The selected
isolates with the most potent anti-inflammatory effect were
characterized to define a potential mechanism of action and we
found that MAPK pathways were regulated. Specifically, E. faecalis
was able to mitigate activation of JNK and p38 coincident with
reduced expression of IL-8 in vitro as well as IL-1b and TNF-a in
vivo.
Enterococci have previously been reported among the common
early colonizers in humans [6]. Thus our study population in
Indonesia provides a surprising consistency of early colonizing
bacteria. Since E.faecalis accounts for 90-95% commensal entero-
cocci in adult human intestines, the finding of E.faecalis as more
prominent than the next most prominent species, E.faecium, is not
unexpected. In our study L.casei was the second most frequently
isolated lactic acid bacteria in 3 day old infants. Although the study
cohort is not big, to our knowledge this is the first report of
lactobacillus among early colonizers, which might reflect environ-
mental differences for this Indonesian cohort.
None of the lactobacilli isolates were strongly immunosuppres-
sive as determined by IL-8 expression levels. Certain E.faecalis
isolates, on the other hand, could strongly inhibit IL-8 in IECs.
Figure 4. Cytokine secretions in HCT116. IL-8 (A) and TNF-a (C) production in HCT116 with the treatment of 2 ng/ml of IL-1b and 107 cfu/ml of
S. typhimurium and E. faecalis (EC16 and EC2) as described in Materials and Methods. (B) IL-8 production in HCT116 with the treatment of TNF-a and E.
faecalis EC16 as described in Materials and Methods. Data was expressed as mean value 6SD. Student’s T-test was used for statistical analysis as
described in Materials and Methods. *p,0.05, **P,0.01.
doi:10.1371/journal.pone.0097523.g004
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Our previous findings showed that E.faecalis can induce anti-
inflammatory cytokine IL-10 in intestinal epithelial through
PPAR-gamma [33]. Taken them together, this may explain lower
abundance enterococcus colonization [34] and high rate of NEC
in preterm infant[35]. Furthermore, infants who developed NEC
carry less E.faecalis [13,36]. Therefore, E.faecalis may possess the
capacity to modulate and attenuate the inflammatory responses
further to prevent inflammatory diseases such as NEC in infants.
Interestingly, the behavior of the three IEC lines differed
substantial in response to many bacteria, suggesting that, in
contrast to standard analyses, the use of a single IEC for
characterization may be inadequate. The anti-inflammatory
effects were confirmed in an in vivo system. This finding is
consistent with previous study showing that E.faecalis has a great
protective effect in DSS-induced experimental colitis model in
mice [37]. It is not clear, at this stage, why only certain isolates of
E.faecalis in this study could reduce IL-8 production in vitro. It will
be interesting to potentially examine these other isolates for their
behavior in DSS-induced colitis model in vivo.
Interestingly, while E.faecalis isolates decreased IL-8 protein level
inside and outside the cells, its mRNA level was upregulated.
Recent researches also showed that MAPK can regulate eIF4E
[38] and eIF4E overexpression is associated with increased IL-8
expression [39]. Therefore, inhibition of MAPK pathway might
suppress eIF4E, which results in reduction in IL-8 translation. In
the DSS-colitis model as well as patients with inflammatory bowel
disease (IBD), p38 levels are increased in the muscularis propria of
colonic tissue [20]. When treated with p38 inhibitor, mucosal IL-
1b and TNF-a levels were reduced in DSS colitis model [21]
consistent with what we found for E.faecalis treatment. Thus, the
phenomena we see with E.faecalis may be exclusively a result of
MAPK inhibition. Alternately, E.faecalis may be affecting other
pathways, for example our previous findings showed LAB can
suppress TLR3, TLR9 and TRAF6 mRNA levels [40]. Therefore
E.faecalis could suppress TLR pathways and further suppress
MAPK pathway as well as NFkB-mediated transcription.
E.faecalis, as one of the first colonizer, could suppress the
inflammatory responses and shape the immune system. Infant
intestine usually undergo acute inflammation when exposed to
Gram-negative bacteria. The presence of E. faecalis may help the
intestine maintain the immune balance in response to such
challenges. Our finding that E.faecalis performed as good as
recognized probiotics indicates their potential to serve as a
probiotic. However, the therapeutic effects must be examined
thoroughly as E.faecalis was also reported as an opportunistic
pathogen in hospital infections. Since we found dead E.faecalis also
have the ability to suppress IL-8 secretion, the use of dead E.faecalis
could mitigate the risk of opportunistic E.faecalis infection.
Materials and Methods
Bacteria culture and Identification
All bacterial strains were isolated from 16 healthy infants in
Indonesia. This study is reviewed and approved by the National
University of Singapore Institutional Review Board (NUS IRB),
approval no. NUS1469. A written consent form was obtained
from participants guardians. The inclusion criteria included
natural birth and breast feeding. The exclusion criteria included
antibiotic intake 2 weeks before and within the study, received
probiotics/culture milk 2 months prior and during the course of
the study.
Those bacteria were first Gram stained followed by API 50 CH
test strips for rod-shaped bacteria and rapid ID 32 STREP test for
the coccal shaped strains. All bacteria strains were then cultured
and extracted for DNA. 16S rDNA were directly sequenced using
primer 1100 reverse 5V-GGGTTGCGCTCGTTG-3V to obtain
partial sequence of the 16S rDNA [41]. Phylogenetic tree
calculation was based on a sequence distance method and utilizes
the Neighbor Joining (NJ) algorithm of Saitou and Nei [42].
Cell culture and Infection
Caco-2, HT-29 and HCT116 were obtained from American
Type Culture Collection (Manassas, VA) and maintained in
ATCC recommended medium. Before cell infection, 16105 cells
were cultured in sterile 24-well flat-bottom plates (Nalge Nunc
International, USA) for 24 hours. Caco-2, HT-29 and HCT116
cells were incubated in fresh medium without (control) or with
bacteria at a multiplicity of infection (MOI) of 100 for 6 hours.
Figure 5. IPA and Realtime PCR analysis. Ingenuity pathway analysis (A) and Real time PCR (B) on E.faecalis treated HCT116 cells. All pathways
and genes showed in the figure were significantly (p,0.05) regulated in HCT116 cells with the treatment of E. faecalis EC16 for 6 h at a MOI of 100.
Experiments were done on 3 biological replicates.
doi:10.1371/journal.pone.0097523.g005
Table 2. Significantly regulated gene (P,0.05) in Caco-2 cells treated with E. faecalis for 6h measured by cDNA microarray.
Functional category Gene population
Response protein GBP1,DUSP1; SLC2A4, NPPB,
Receptors EGFR;IL8RA, TNFRSF11A, P2RX7
Transcription factors MLLT7, EGR1, ETS1;MAPKAPK2, MAPKAPK3, MAX, MEF2B, MKNK1, SP1
AKT& PI3K family PIK3R3, TCL1A, TCL1B
MAKP family MAPK13;MAPK7, MAP4K1
Adaptor TNFAIP3, MDM2;
Nuclear factors NCOA1, SPI1
Signal transduction kinases IKBKB, MAP3K7IP1, PRKCA
Rel/NF-kb NFKB1, NFKBIL2, NFKB2
Others SMAD4, SMAD1, BCL2; NFATC2, NCK2, PPP3CB, PPP3CC, CTLA4, SMAD6.
Note: Bold italic labeled genes are those upregulated. The rest are downregulated genes.
doi:10.1371/journal.pone.0097523.t002
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Supernatants were harvested for ELISA assay (BD bioscience, San
Diego, CA). and proteins were harvested for Western blotting
analysis.
Conditional Medium and Cell Inserts
The cell culture supernatants obtained from IECs, bacteria and
coculture of bacteria and IECs were harvested sterilely and
conditional media were then added to the cell cultures prepared.
The supernatant were then collected for cytokines assay. For cell
inserts test, HCT116 cells were plated in wells of Transwell (USA)
multiple well plate. 100 ml of bacterial suspensions were added to
each insert. To sonicate bacterial cells, protease inhibitors were
added to the suspensions. The bacterial cells were then disrupted
by sonication (SANYO, Japan) on ice for 10 cycles with 30 sec
pulses and 1min rest [43]. Cell debris was pelleted down and
added in the cell culture prepared as above. Another bacterial
suspensions were exposed to UV light for 5 min [44] to make sure
at least 99% bacteria were killed and then co-culture with cells.
TNF-a, IL-1b and S. typhimurium induced cytokine
secretion and protein production
200 ng/ml TNF-a (Preproteck, INC, rocky hill, NJ), 0.2 ng/ml
IL-1b (Preproteck, INC, rocky hill, NJ) and S. typhimurium at a
MOI of 100 were added to Caco-2 and HCT116 cells. Cells were
then infected with E. faecalis EC16 with or without TNF-a/IL-1b/
S. typhimurium. Cells without any treatment were used as controls.
The cells were then cultured at 37uC with 5% CO2 for 30 mins,
1 h, 2 h, 4 h and 6 h. Supernatants were collected and the
concentration of IL-8 was determined by ELISA (BD bioscience,
San Diego, CA). Other cytokines like INF-c, TNF-a, IL-2, IL-5,
IL-17 and ICAM-1 were determined using cytokine assay (Bio-
Rad, USA). The proteins were harvested for Western blotting
assay.
Microarray analysis
A total of 406 human immunology signaling pathway related
cDNA clones were detected in this study (Superarray, USA)
according to manufacture’s instruction. Raw data are available at
Gene Expression Omnibus with accession number of GSE56485.
Signals were analyzed using the web-based GEArray Expression
Analysis Suite (Supperarray, US). GeneSpring GX 7.3.1 and
Ingenuity pathway analysis was also used to analyze the data. Data
were excluded with bad or absent flags. In this experiment, 2-3
replicates were done for one treatment. Student t test was applied
for controlling the false-positive rate (P,0.05 was considered
significant), clustering analysis was generated by the software.
TaqMan Low Density Array (TLDA)
The RNA was harvested using the RNA extraction kit (Roche,
Switzerland). A 48-well format Taqman low density array was
designed for a subset of genes that were differentially expressed in
the array experiments including two endogenous controls 18 s and
b-actin (Applied Biosystems, USA). Genes and ABI assay IDs are
listed in Table S1. 0.5 mg total RNA was converted to cDNA using
High-Capacity cDNA archive kit (Applied Biosystems, USA) and
10 ng cDNA in 100 ml TaqMan universal PCR master mix
(Applied Biosystems, USA) was used for each port and run on an
ABI 7900 system (Applied Biosystems, USA). Data was analyzed
using the SDS2.2 software where baseline and threshold settings
were automatically adjusted.
Sodium-Dodecyl Sulfate-Polyacrylamide Gel
Electrophoresis (SDS-PAGE) and immuno blotting
Sodium-dodecyle sulfate-polyacrylamide gel electrophoresis was
performed on a 10% gel by using 20 mg per lane of whole cell
lysate. Electrophoresis was carried out using consistent voltage of
75 volts for approximately one and a half hour and then
transferred onto a 0.22 mm Nitrocellulose membrane (Biorad,
USA) at 85 volts for 2 hours in cold room. The membrane was
then blocked in Tris buffer saline-Tween (TBST) containing 5%
skim milk for at least 1 h. Specific primary antibodies were then
diluted and the membrane was incubated overnight at 4 uC on an
orbital shaker (Bellco, USA). After washing, appropriate horse-
radish peroxidase (HRP)-conjugated secondary antibodies diluted
in TBST containing 5% skim milk were added into the membrane
and incubated for 1 hour at room temperature on an orbital
shaker (Bellco, USA). Visualization of the immunolabeled bands
was then carried out using ECL Plus Western Blotting Detection
Reagents or ECL Advance Western Blotting Detection Kit (GE
Healthcare, UK) according to manufacturer’s instruction. The
signals were exposed on X-ray film (Koda, USA).
Animals
Male C57BL/6 mice (8 to 10 weeks of age) were kept in
SingHealth Experimental Medicine Centre and housed in
collective cages at 2261uC under a 12-h light/dark cycle (lights
on at 07:00 h) with free access to laboratory chow and autoclaved
tap water. Experiments were performed during the light phase of
the cycle. The experimental procedures were previously approved
by SingHealth Institutional Animal Care and Use Committee
(IACUC) on the Ethical Use of Animals, where the study was
carried out, and were conducted in accordance with Singapore
regulations on animal welfare.
Figure 6 Protein expression in HCT116JNK expression (A) at
30 mins, c-JUN (B) and P38 (C) expression at 1 h in HCT116
with the treatment of 2 ng/ml of IL-1b and 107 cfu/ml of S.
typhimurium, E. faecalis EC16 as described in Materials and
Methods. Cells were then lysed and proteins were tested using
western blot. Three independent experiments were done.
doi:10.1371/journal.pone.0097523.g006
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DSS induced mild colitis model in mice
Male C57BL/6 mice (n=6–8 per group) were provided with a
solution of filtered water containing 1.5% dextran sodium sulfate
(DSS) (TdB Consultancy AB, Uppsala, Sweden) over a 12-day
period. Every other day, the total of 200 ml of 1.5% DSS solution
was replenished. The total volume of DSS solution consumed per
mouse was proximally 4.4 ml/day. No differences between
experimental groups were observed. On the third day of 1.5%
Figure 7. E.faecalis treated DSS mild colitis model. Colon lengths (cm) (A) and Mice weight change (B) with 1.5% DSS with or without EC16 and
L.GG treatment as described in Material and Method. Real time PCR on IL-1b (C) and TNF-a (D) expression in colon. Each group contains 6–8 mice.
Data was expressed as mean value 6SD. Student’s T-test was used for statistical analysis as described in Materials and Methods. * p,0.05, ** P,0.01.
doi:10.1371/journal.pone.0097523.g007
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DSS treatment, treatment group were fed with 10‘7 CFU/100 ml
EC16 or 10‘7 CFU/100 ml L.GG using a gavage needle
respectively. Control group were fed with PBS. The animals were
provided with 1.5% DSS till day 12. On day 12, the animals were
euthanized, colon were removed for length measurement and
frozen in liquid nitrogen for future analysis.
Statistical analysis
Data are expressed as means 6 SD. Significance of differences
was determined using the Student’s T-test and analysis of variance.
P values,0.05 were considered to be statistically significant.
Supporting Information
Figure S1 IL-8 secretions in Caco-2 (A), HT-29 (B) and
HCT116 (C) with the treatment of Lactobacillus and
apoptosis assay in HCT116 (D,E). A total number of
107 cfu/ml bacteria were added into the cells for 6 h. Superna-
tants were harvested for cytokine assay as described in Materials
and Methods. Three independent experiments were compiled to
produce the data shown. Data were expressed as mean value
6SD. D. Apoptosis assay in HCT116 control. E. Apoptosis assay
in HCT116 with EC16 treatment. One representative assay was
shown from three independent experiments.
(TIF)
Figure S2 Cytokine productions in IECs. IL-8 production
inside HCT116 cells (A, B), IL-8 secretion (C) and ICAM1, IL-2,
IL-5, IL-17, IFN-c and TNF-a in Caco-2 cells (D) with the
treatment of 2 ng/ml of IL-1b and 107 cfu/ml of S. typhimurium
and E. faecalis (EC16 and EC2) as described in Materials and
Methods. Three replicates were done. Data was expressed as mean
value 6SD.
(TIF)
Figure S3 Gene expression in Caco-2 cells tested using
cDNA microarray. (A) The original photo of EC16 after
exposure. (B) Volcano plot of EC16 obtained using Gene Spring
software. Red dots represent the significantly changed genes.
Yellow dots represent the genes not be regulated significantly.
Only one of five sets of EC16 data were used as a representation.
(TIF)
Figure S4 Real-time PCR on E.faecalis treated HCT116
(dot) and Caco2 (black) cells. Experiments were done on 3-4
biological replicates and 2 technical replicates. Folds changes.1.5
and T-test with a P,0.05 was considered significant change.
(TIF)
Figure S5 ERK expression in HCT116 cells at 30 mins
with the treatment of 2 ng/ml of IL-1b and S. typhimur-
ium with and without E. faecalis EC16 at a MOI of 100.
Total protein was harvested and protein production was analyzed
using Western blotting as described in Materials and Methods.
Experiments were repeated three times.
(TIF)
Table S1 Gene ID and Taqman Primers ID.
(DOCX)
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